ArticleCureus2026
Paraneoplastic Opsoclonus Without Myoclonus Secondary to High-Grade Serous Carcinoma in an Adult.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opsoclonus is a rare disorder characterized by chaotic, multidirectional eye movements and most commonly presents as part of the opsoclonus-myoclonus syndrome (OMS). Although typically described in pediatric populations, particularly in association with neuroblastoma, adult presentations are exceptionally rare and are most often paraneoplastic or infectious in origin. We describe the case of a woman in her 60s who developed isolated opsoclonus associated with a newly diagnosed poorly differentiated metastatic high-grade serous carcinoma. The clinical course, diagnostic evaluation, antibody profiling, and immunomodulatory treatments, including intravenous immunoglobulin (IVIG), corticosteroids, and plasmapheresis, are reviewed. This case highlights the diagnostic challenges and therapeutic considerations associated with adult-onset paraneoplastic opsoclonus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.